Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 02, 2026
TickeronGET DAILY SIGNALS
Green Brick Partners (GRBK): Assessing the Potential +11% Move Toward $71

Green Brick Partners (GRBK): Assessing the Potential +11% Move Toward $71

Key Takeaways

  • The central target of $71 is the average of the two verified analyst targets above the current price — Texas Capital Securities at $71 and Wedbush at $70 — not a broad consensus.
  • Only a small number of credible, current targets exist; the full reviewed range is roughly $62 to $71, and the overall mean of all valid targets is about $68.
  • Shares recently traded near $64, meaning the target implies roughly an 11% upside, a modest move relative to the stock's past volatility.
  • Supporting factors include a land-heavy model, industry-leading returns, and fast-growing mortgage operations; the biggest risks are declining EPS and rising buyer incentives.
  • Analyst sentiment is broadly Neutral/Hold, with recent actions including a downgrade by Texas Capital Securities and Neutral ratings from B. Riley Securities, Wedbush, and BTIG.
  • Readers can find more detail on Major News, Today's Price Move, the Forecast, and Earnings on dedicated pages.
  • Explore Trending AI Robots to see how automated strategies are interpreting changing market conditions.

Understanding the Analyst Targets

Coverage of GRBK remains relatively thin, and the analyst community appears cautious overall. The reviewed targets cluster tightly: B. Riley Securities maintains a Neutral rating with a $62 target, Wedbush reiterates Neutral at $70, and Texas Capital Securities holds a Hold rating at $71 after downgrading from Buy. This produces a range of roughly $62 to $71 and an overall mean near $68, sitting only modestly above recent prices.

Because that overall mean does not clear a meaningful margin above the current price, the $71 central target is calculated as the average of the two targets above the price — $71 and $70. It is not an official published consensus. The prevailing Hold/Neutral stance reflects analysts' view that profitability and returns remain strong, yet near-term earnings face pressure. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Where the Stock Stands Now

Shares recently traded near $64, toward the lower end of a 52-week range of roughly $59 to $83. Reaching $71 would require a move of about 11%, a modest advance by the standards of a stock with weekly swings averaging around 5%. The path depends on whether Green Brick can stabilize margins and show that its entry-level-focused growth platform can offset the earnings decline currently embedded in estimates.

The stock trades at a low-teens P/E multiple on trailing earnings, but consensus forecasts point to EPS easing from about $6.94 in fiscal 2025 toward the low-$6 range over the next two years. A target of $71 implicitly assumes the market rewards improving trends rather than extrapolating the current earnings downturn.

Factors That Could Drive the Move Higher

  • Best-in-class returns: the company reported a 16% return on equity and an 11.8% return on assets, far above the roughly 4.7% peer median.
  • Land-heavy, self-development model: roughly 76% of its approximately 52,000 lots are owned, supporting higher margins and pacing control.
  • Mortgage growth: Green Brick Mortgage's funded loans rose 257% year over year, with 65% of loans going to first-time buyers.
  • Growth runway: Trophy Signature Homes is expanding in Dallas-Fort Worth, Houston, and Austin, targeting affordable price points with durable demand.

Risks That Could Hold the Stock Back

  • Declining earnings: net income fell 9.5% year over year in the latest quarter, with diluted EPS down 8% to $1.70.
  • Margin compression: discounts and incentives rose to 8.8% of home closings revenue, and homebuilding gross margin declined 150 basis points.
  • Mix shift: a higher share of lower-priced Trophy homes pushed average selling prices and revenue down even as delivery volumes held steady.
  • Cautious sell-side: with analysts mostly at Hold/Neutral and one recent downgrade, there is limited upward pressure from rating revisions.
  • Rate sensitivity: as a homebuilder, demand and affordability remain tied to mortgage rates and the broader housing cycle.

Technical Levels to Watch

The stock's 52-week low near $59 represents a key support zone, while the $70-to-$71 area — where the above-price analyst targets cluster — marks the immediate resistance band that would need to be cleared. Further overhead sits at the 52-week high near $83. The shares remain well below that prior peak, leaving the long-term trend corrective until a sustained reclaim of the low-$70s occurs.

Time Horizon and Items to Monitor

Analyst price targets generally reflect a roughly 12-month research horizon, though the specific dates of the underlying reports vary. Key items to watch include quarterly earnings and any changes to guidance, the trajectory of gross margins and buyer incentives, the mix of Trophy Signature Homes deliveries, mortgage-rate moves and related FOMC decisions, and any revisions or new initiations from the limited analyst coverage.

Using AI Tools for Ongoing Monitoring

In my research process, I frequently rely on Tickeron's AI Daily Buy/Sell Signals to track how automated systems are interpreting GRBK's price action alongside broader market signals. This helps me stay objective when weighing analyst views against technical trends and changing conditions.

Final Assessment

The $71 target for Green Brick Partners is best understood as the average of the two analyst targets above the current price, not a broad Wall Street consensus. It implies a modest, roughly 11% move from recent levels near $64. Supporting the case are the company's industry-leading returns, its controlled land supply, and a rapidly growing mortgage segment; working against it are declining earnings, margin pressure, a lower-priced product mix, and a cautious Hold-leaning analyst community. Whether the shares approach $71 will depend on stabilization in margins and any signs that earnings estimates have bottomed. No outcome is guaranteed, and the target should be treated as a reference point rather than a forecast.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GRBK

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


GRBK saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for GRBK moved out of overbought territory on October 29, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 66 similar instances where the indicator exited the overbought zone. In 45 of the 66 cases the stock moved lower. This puts the odds of a downward move at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for GRBK moved below the 200-day moving average on October 07, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GRBK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

The Aroon Indicator for GRBK entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GRBK's RSI Oscillator exited the oversold zone, 16 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on GRBK as a result. In 58 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for GRBK just turned positive on October 22, 2026. Looking at past instances where GRBK's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.

GRBK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 31 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.422) is normal, around the industry mean (1.847). P/E Ratio (9.569) is within average values for comparable stocks, (10.066). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.217). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (1.421) is also within normal values, averaging (24.205).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. GRBK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

Notable companies

The most notable companies in this group are DR Horton (NYSE:DHI), Pultegroup (NYSE:PHM), Lennar Corp (NYSE:LEN), KB Home (NYSE:KBH).

Industry description

Homebuilding includes companies residential home construction companies, renovators and repair firms. The companies may be building single-family or multifamily homes, condominiums or mobile homes. Over the five years to 2019, the Home Builders industry is estimated to have grown at an annualized rate of 2.5% to reach $89.4 billion, (including expected growth of 2.6% in 2019), according to a study by IbisWorld. After having suffered one of its worst crises a decade ago during the last macroeconomic recession–which had much of its origins in U.S. real estate – the homebuilding industry has been recovering steadily so far. Higher disposable incomes and improving economic activity have bolstered consumers’ purchases of homes. While revenue of the Home Builders industry remains well below its prerecession high, demand growth estimates show promise.

Market Cap

The average market capitalization across the Homebuilding Industry is 7.8B. The market cap for tickers in the group ranges from 12.75K to 42.77B. DHI holds the highest valuation in this group at 42.77B. The lowest valued company is BDCC at 12.75K.

High and low price notable news

The average weekly price growth across all stocks in the Homebuilding Industry was 6%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 5%. CVCO experienced the highest price growth at 25%, while BXBL experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Homebuilding Industry was 32%. For the same stocks of the Industry, the average monthly volume growth was 8% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 31
Price Growth Rating: 58
SMR Rating: 71
Profit Risk Rating: 65
Seasonality Score: 57 (-100 ... +100)
View a ticker or compare two or three
GRBK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a constructor of residential homes and provider of land development services

Industry Homebuilding

Industry
Homebuilding
Address
5501 Headquarters Drive
Phone
+1 469 573-6755
Employees
620
Web
https://www.greenbrickpartners.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Shares of Brookfield Infrastructure Corporation (BIPC) are down approximately 11% on Wednesday, trading near $35.44 after closing at $39.82 on April 28, following the release of Q1 2026 earnings before the market open. Primary catalyst: Q1 2026 results showed a GAAP net loss of $61 million, a sharp reversal from net income of $125 million in Q1 2025 — a $186 million year-over-year deterioration.
Shares of Regeneron Pharmaceuticals (REGN) are down approximately 6% on Wednesday, trading near $688 after closing at $731.77 on April 28, in an earnings-driven selloff despite a headline beat on both EPS and revenue. Primary catalyst: A sharp "beat and sell" market reaction driven by the continued deterioration of the core EYLEA franchise — total U.S. EYLEA HD and EYLEA net sales declined 10% year-over-year to $941 million, more than offsetting record Dupixent growth.